Abstract
A hospital-based case-control study of ovarian cancer was conducted in London and Oxford between October 1978 and February 1983. Menstrual characteristics, reproductive and contraceptive history and history of exposure to various environmental factors were compared between 235 women with histologically diagnosed epithelial ovarian cancer and 451 controls. High gravidity, hysterectomy, female sterilisation and oral contraceptive use were associated with a reduced risk of ovarian cancer. Infertility and late age at menopause were associated with an increase in risk. While these factors were related, they were each found to be independently associated with ovarian cancer risk after adjusting for the effect of the other factors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Booth, M., Beral, V. & Smith, P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 60, 592–598 (1989). https://doi.org/10.1038/bjc.1989.320
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.320
This article is cited by
-
Association Between the Frequent Use of Perineal Talcum Powder Products and Ovarian Cancer: a Systematic Review and Meta-analysis
Journal of General Internal Medicine (2022)
-
Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer
BMC Cancer (2020)
-
Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions
Modern Pathology (2020)
-
Tubal ligation and ovarian cancer risk in African American women
Cancer Causes & Control (2017)
-
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
Journal of Cancer Research and Clinical Oncology (2016)